Pneumococcal conjugate second or third-dose vaccines (PCVc) in Singapore
Singapore: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 91.0% in 2025. ▲ Rising
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Singapore, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Singapore recorded 91.0% for pneumococcal conjugate second or third-dose vaccines (pcvc) in 2025.
Compared with earlier readings it is up 21.3% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Singapore peaked at 93.0% in 2023 and was at its lowest, 0.0%, in 2008.
Singapore ranks 61st of 194 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 18 years of available data.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Singapore, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 17.0% | — |
| 2010 | 22.0% | +29.4% |
| 2011 | 40.0% | +81.8% |
| 2012 | 52.0% | +30.0% |
| 2013 | 60.0% | +15.4% |
| 2014 | 68.0% | +13.3% |
| 2015 | 75.0% | +10.3% |
| 2016 | 78.0% | +4.0% |
| 2017 | 83.0% | +6.4% |
| 2018 | 84.0% | +1.2% |
| 2019 | 84.0% | +0.0% |
| 2020 | 87.0% | +3.6% |
| 2021 | 88.0% | +1.1% |
| 2022 | 90.0% | +2.3% |
| 2023 | 93.0% | +3.3% |
| 2024 | 91.0% | -2.2% |
| 2025 | 91.0% | +0.0% |
Singapore compared with similar countries
- Singapore's 91.0% is above the median for high income countries, which is 91.0%, 1.0× the median. (63 countries reporting)
- Singapore's 91.0% is above the median for East Asia & Pacific, which is 81.0%, 1.1× the median. (30 countries reporting)
Biggest year-on-year movements
Years where Pneumococcal conjugate second or third-dose vaccines (PCVc) in Singapore changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2011 | +81.8% | 22.0% | 40.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 8.5% | 0.0% | 17.0% | 2 |
| 2010s | 64.6% | 22.0% | 84.0% | 10 |
| 2020s | 90.0% | 87.0% | 93.0% | 6 |
Countries ranked near Singapore
More health data for Singapore
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5225 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,924 deaths per 1,000 people (2090)
- Number of infants who die before age 1 13 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2024)
- Population ages 00-04, female, annual growth rate 1.93 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0196 units per person (2025)
- Population ages 00-04, male, annual growth rate 2.52 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Singapore?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Singapore was 91.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Singapore?
- The highest recorded value was 93.0% in 2023.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Singapore?
- The lowest recorded value was 0.0% in 2008.
- How does Singapore rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Singapore ranks 61st out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Singapore?
- Over the last ten years it is up 21.3%. The long-run trend across the full record is rising.
- Where does this Singapore data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).